Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4192.0
(-2.58%)
JPY 4192.0
(-2.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 38.22 Billion JPY | -3.37% |
| 2022 | 39.55 Billion JPY | -4.86% |
| 2021 | 41.57 Billion JPY | 1.64% |
| 2020 | 40.9 Billion JPY | -18.97% |
| 2019 | 50.48 Billion JPY | -6.17% |
| 2018 | 53.8 Billion JPY | -3.97% |
| 2017 | 56.02 Billion JPY | -2.48% |
| 2016 | 57.45 Billion JPY | -6.79% |
| 2015 | 61.63 Billion JPY | 25.45% |
| 2014 | 49.13 Billion JPY | 12.23% |
| 2013 | 43.78 Billion JPY | 4.03% |
| 2012 | 42.08 Billion JPY | -2.28% |
| 2011 | 43.06 Billion JPY | 1.66% |
| 2010 | 42.36 Billion JPY | 3.56% |
| 2009 | 40.9 Billion JPY | 2.81% |
| 2008 | 39.78 Billion JPY | 2.81% |
| 2007 | 38.69 Billion JPY | 4.04% |
| 2006 | 37.19 Billion JPY | 0.43% |
| 2005 | 37.03 Billion JPY | -0.37% |
| 2004 | 37.17 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 10.05 Billion JPY | 11.82% |
| 2023 Q1 | 10.05 Billion JPY | 11.82% |
| 2023 FY | 38.22 Billion JPY | -3.37% |
| 2023 Q4 | 8.67 Billion JPY | -14.4% |
| 2023 Q3 | 10.13 Billion JPY | 4.9% |
| 2023 Q2 | 9.66 Billion JPY | -3.89% |
| 2022 Q4 | 8.99 Billion JPY | -11.63% |
| 2022 Q1 | 10.04 Billion JPY | 5.05% |
| 2022 Q2 | 10.34 Billion JPY | 3.06% |
| 2022 Q3 | 10.17 Billion JPY | -1.65% |
| 2022 FY | 39.55 Billion JPY | -4.86% |
| 2021 Q1 | 10.27 Billion JPY | 12.87% |
| 2021 Q2 | 10.72 Billion JPY | 4.36% |
| 2021 Q3 | 11.01 Billion JPY | 2.75% |
| 2021 Q4 | 9.55 Billion JPY | -13.27% |
| 2021 FY | 41.57 Billion JPY | 1.64% |
| 2020 Q3 | 10.91 Billion JPY | 3.9% |
| 2020 FY | 40.9 Billion JPY | -18.97% |
| 2020 Q2 | 10.5 Billion JPY | 1.1% |
| 2020 Q1 | 10.38 Billion JPY | 2.29% |
| 2020 Q4 | 9.1 Billion JPY | -16.57% |
| 2019 Q4 | 10.15 Billion JPY | -29.65% |
| 2019 Q1 | 12.82 Billion JPY | 6.97% |
| 2019 Q2 | 13.06 Billion JPY | 1.83% |
| 2019 Q3 | 14.43 Billion JPY | 10.5% |
| 2019 FY | 50.48 Billion JPY | -6.17% |
| 2018 FY | 53.8 Billion JPY | -3.97% |
| 2018 Q4 | 11.99 Billion JPY | -15.93% |
| 2018 Q3 | 14.26 Billion JPY | 5.08% |
| 2018 Q1 | 13.96 Billion JPY | 20.21% |
| 2018 Q2 | 13.57 Billion JPY | -2.81% |
| 2017 Q2 | 14.51 Billion JPY | 0.46% |
| 2017 Q4 | 11.62 Billion JPY | -24.77% |
| 2017 Q3 | 15.44 Billion JPY | 6.42% |
| 2017 Q1 | 14.44 Billion JPY | 16.53% |
| 2017 FY | 56.02 Billion JPY | -2.48% |
| 2016 Q2 | 14.86 Billion JPY | -1.16% |
| 2016 Q3 | 15.15 Billion JPY | 1.98% |
| 2016 Q4 | 12.39 Billion JPY | -18.2% |
| 2016 FY | 57.45 Billion JPY | -6.79% |
| 2016 Q1 | 15.03 Billion JPY | 20.98% |
| 2015 Q3 | 17.65 Billion JPY | 11.98% |
| 2015 Q4 | 12.42 Billion JPY | -29.59% |
| 2015 FY | 61.63 Billion JPY | 25.45% |
| 2015 Q2 | 15.76 Billion JPY | -0.18% |
| 2015 Q1 | 15.79 Billion JPY | 30.76% |
| 2014 Q2 | 11.85 Billion JPY | 9.4% |
| 2014 Q3 | 14.36 Billion JPY | 21.11% |
| 2014 Q4 | 12.07 Billion JPY | -15.9% |
| 2014 FY | 49.13 Billion JPY | 12.23% |
| 2014 Q1 | 10.83 Billion JPY | -1.98% |
| 2013 Q4 | 11.05 Billion JPY | -3.25% |
| 2013 FY | 43.78 Billion JPY | 4.03% |
| 2013 Q1 | 10.35 Billion JPY | 10.43% |
| 2013 Q2 | 10.94 Billion JPY | 5.71% |
| 2013 Q3 | 11.42 Billion JPY | 4.45% |
| 2012 Q2 | 11.19 Billion JPY | 10.82% |
| 2012 FY | 42.08 Billion JPY | -2.28% |
| 2012 Q1 | 10.09 Billion JPY | 2.04% |
| 2012 Q3 | 11.42 Billion JPY | 2.08% |
| 2012 Q4 | 9.37 Billion JPY | -17.95% |
| 2011 Q4 | 9.89 Billion JPY | -14.8% |
| 2011 Q1 | 10.47 Billion JPY | 9.79% |
| 2011 Q2 | 11.08 Billion JPY | 5.8% |
| 2011 Q3 | 11.61 Billion JPY | 4.82% |
| 2011 FY | 43.06 Billion JPY | 1.66% |
| 2010 Q1 | 10.97 Billion JPY | 22.23% |
| 2010 Q4 | 9.54 Billion JPY | -16.74% |
| 2010 Q3 | 11.45 Billion JPY | 10.23% |
| 2010 Q2 | 10.39 Billion JPY | -5.24% |
| 2010 FY | 42.36 Billion JPY | 3.56% |
| 2009 Q2 | 10.23 Billion JPY | 0.27% |
| 2009 Q3 | 11.48 Billion JPY | 12.2% |
| 2009 Q4 | 8.97 Billion JPY | -21.86% |
| 2009 FY | 40.9 Billion JPY | 2.81% |
| 2009 Q1 | 10.2 Billion JPY | 16.2% |
| 2008 Q4 | 8.78 Billion JPY | -19.81% |
| 2008 FY | 39.78 Billion JPY | 2.81% |
| 2008 Q3 | 10.95 Billion JPY | 8.25% |
| 2008 Q2 | 10.12 Billion JPY | 0.0% |
| 2007 FY | 38.69 Billion JPY | 4.04% |
| 2006 FY | 37.19 Billion JPY | 0.43% |
| 2005 FY | 37.03 Billion JPY | -0.37% |
| 2004 FY | 37.17 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 21.599% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 98.251% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 79.667% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 89.644% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -979.459% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 60.603% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 93.482% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -537.246% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 51.6% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 26.595% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -182.77% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -393.952% |
| Tsumura & Co. | 68.81 Billion JPY | 44.458% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -2.359% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -54.171% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 53.034% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -131.438% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 23.832% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 25.638% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -3442.354% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -288.474% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -766.513% |
| MedRx Co., Ltd | 26 Million JPY | -146907.692% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -376.244% |
| Solasia Pharma K.K. | 337 Million JPY | -11241.84% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 5228827.77% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -24.644% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 29.634% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -101166.426% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 66.171% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -475.667% |